Dow Up0.36% Nasdaq Up0.12%

More On INNV


Innovus Pharmaceuticals, Inc. (INNV)

-Other OTC
0.24 Up 0.06(33.33%) 3:42PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 166   6   0   0  
Cost of Revenue56  2  (0)0  
Gross Profit 110   4   0   0  
Operating Expenses
Research Development56  27  66   -  
Selling General and Administrative1,286  714  648  2,107  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,231) (736) (714) (2,107)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes(1,231)(736)(714)(2,107)
Interest Expense208  32  20  11  
Income Before Tax(1,439)(768)(734)(2,117)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,439)(768)(734)(2,117)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,439) (768) (734) (2,117)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,439) (768) (734) (2,117)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.